六对三个剂量内性链激酶在儿童肺:一个随机对照试验

Chirag Thakur1, Joseph L Mathew1, Akshay K Saxena2

  • 1Department of Pediatrics, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Pediatric pulmonology
|December 31, 2024
PubMed
概括

对于儿科肺炎,服用六剂内链激酶 (SK) 治疗的效果不大于三剂. 这种六剂疗法是安全的,但不会改善患有 empyema 的儿童的治疗结果.